BUZZ-Tekmira Pharmaceuticals Corp: Potential takeover target - Barrons
** Canadian drug developer's U.S.-listed shares up 7 pct at $21.12
** Company developing Ebola drug likely takeover target - Barrons (on.barrons.com/1sI6iAR)
** GlaxoSmithKline Plc experimental Ebola vaccine being fast-tracked into human studies
** WHO hoping for improved supplies of experimental treatments and progress with vaccine by year-end after backing use of untested therapies earlier this month
** Ebola epidemic has killed more than 1,500
© Thomson Reuters 2017 All rights reserved.